“We are glad to announce that our qTerm, AI-driven human vitals measurements device, non-provisional patent has received a notice of allowance and is expected to be granted within the next upcoming months. This technology is planned to be marketed and sold for personal and clinics usage and also targeting the telemedicine arena. We consider our qTerm Device intellectual property as one of our major patents and plan to expand its protection along with improving its technology, in efforts to create an intelligent, personal health assistant for everyone” stated Danny Rittman, the Company’s CTO.
